Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
81.1M
-
Shares change
-
+207K
-
Total reported value, excl. options
-
$1.82B
-
Value change
-
-$59.6M
-
Put/Call ratio
-
0.26
-
Number of buys
-
95
-
Number of sells
-
-103
-
Price
-
$22.41
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) as of Q3 2023
236 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share as of Q3 2023.
PTC THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PTCT) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.1M shares
.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (9.44M shares), FMR LLC (8.47M shares), VANGUARD GROUP INC (7.95M shares), RTW INVESTMENTS, LP (7.24M shares), BlackRock Inc. (6.93M shares), ARMISTICE CAPITAL, LLC (6.15M shares), Camber Capital Management LP (3.4M shares), STATE STREET CORP (3.17M shares), JANUS HENDERSON GROUP PLC (3.07M shares), and FRANKLIN RESOURCES INC (2.06M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.